The initiation of coverage by TD Cowen with a Market Perform rating suggests that the analyst believes P3 Health Partners' stock will perform similarly to other stocks in the market. This could potentially attract new investors, but it's not necessarily a strong buy signal. Therefore, the short-term impact on the stock price is neutral.